StonvexLoading…
StonvexStonvexStonvexCore line items from THRY's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $785.01M | $824.16M | $916.96M | $1.20B |
Operating Income | $56.71M | $-33.30M | $-200.02M | $99.32M |
Net Income | $307.00K | $-74.22M | $-259.30M | $54.35M |
EPS (Diluted) | $0.01 | $-2.00 | $-7.47 | $1.49 |
Total Assets | $688.59M | $712.16M | $783.17M | $1.18B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $10.75M | $16.31M | $18.22M | $16.03M |
Free Cash Flow OCF − CapEx | $31.14M | $56.25M | $114.83M | $119.34M |
Shares Outstanding | 43.82M | 43.03M | 35.30M | 34.59M |